| Record ID | ia:behavioralpharma0000unse_h6i5 |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/behavioralpharma0000unse_h6i5/behavioralpharma0000unse_h6i5_marc.xml |
| Download MARC binary | https://www.archive.org/download/behavioralpharma0000unse_h6i5/behavioralpharma0000unse_h6i5_meta.mrc |
LEADER: 01136cam a2200277 i 4500
001 76008408
003 DLC
005 20130720074458.0
008 760323s1975 mduaf b 101 0 eng
010 $a 76008408
020 $a0306345048
040 $aDLC$cDLC$dDLC
050 00 $aRM315$b.B358
082 00 $a615/.78
245 00 $aBehavioral pharmacology :$bthe current status /$cedited by Bernard Weiss and Victor G. Laties.
260 $aBethesda [Md.] :$bFASEB,$cc1975.
300 $avii, 301 p., [2] leaves of plates :$bill. ;$c24 cm.
440 0 $aFASEB monographs ;$vv. 4
500 $aContains papers given at the 2-day symposium, which took place at the Federation of American Societies for Experimental Biology meetings in 1974.
500 $a"Originally appeared in Federation proceedings, vol. 34, no. 9, August 1975."
504 $aIncludes bibliographies and index.
650 0 $aPsychopharmacology$xCongresses.
650 0 $aBehavior modification$xCongresses.
700 1 $aWeiss, Bernard,$d1925-
700 1 $aLaties, Victor G.
710 2 $aFederation of American Societies for Experimental Biology.$tFederation proceedings.